Dianthus Therapeutics, Inc.
DNTHNASDAQ
USReal-Time Price
USReal-Time Price$78.10USD
-0.65 (-0.83%)Today
$78.00-0.10 (-0.13%)Pre-Market7:36 AM ET
BTI Score
Near Future
51
Long Term
49
BTI Fair Market Cap
$1.35B
+222.71% vs fair
Biotechnology
High Risk
Dianthus Therapeutics, Inc. (DNTH) Valuation
Is Dianthus Therapeutics, Inc. (DNTH) overvalued or undervalued? BTI's fair-value estimate, DCF model and valuation multiples show the premium or discount to intrinsic worth.
Valuation Snapshot
P/E (TTM)
Trailing Price-to-Earnings
—
Forward P/E
Next 12 months estimate
—
PEG Ratio
P/E to Growth ratio
—
Price / Sales
Market cap vs. revenue
—
Price / Book
Market cap vs. book value
—
EV / EBITDA
Enterprise value multiple
—
Earnings Yield
Inverse of P/E
—
Revenue Growth
Year-over-year
—
Valuation Risk
Dianthus Therapeutics, Inc.'s valuation multiples are within a moderate range, suggesting the market is not pricing in excessive optimism. Investors should monitor growth execution relative to valuation.
Run Full Valuation Model
DCF, multiples, scenario analysis and AI fair value for DNTH